ALFATRAN (ALFATRAN) Fair Value & Analysis

IN · Market cap ₹381M

A ALFATRAN ALFATRAN · BSE

Price₹41.69

Fair Value₹25.70

Upside-38.4%

Quality38/100

Watch ALFATRAN for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range ₹13.33 – ₹39.03

Fair value as of: Jul 5, 2026

From 4 valuation models · updated today

Share price −7.5% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹28.58 – ₹71.66 · fair‑value band ₹13.33 – ₹39.03 · the ₹41.69 price screens above the ₹25.70 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ALFATRAN (ALFATRAN) currently trades at ₹41.69, while our model-based Fair Value estimate is ₹25.70 — implying the stock looks roughly 38.4% overvalued today. We read business quality at 38/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, ALFATRAN generated revenue of ₹319M at a net margin of -5.0%. Revenue declined 20.8% year over year. It earns a return on equity of -7.2%. Net debt stands at ₹118M. Fundamentals as of Jul 5, 2026

Key figures & financial health

Revenue (TTM) ₹319M

Revenue growth (YoY) -20.8%

Net margin -5.0%

Return on equity -7.2%

Free cash flow −₹8.6M FY2026

Operating margin -14.3%

More key figures

EPS (TTM) ₹-1.75

EPS growth (YoY) +4.7%

Net debt ₹118M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ALFATRAN reported revenue of ₹319M in FY2026 versus ₹95.7M in FY2022, a compound +35.1%/yr. Reported net income was −₹15.9M in FY2026.

Revenue +35.1%/yr

FY22 ₹95.7M

FY23 ₹290M

FY24 ₹509M

FY25 ₹502M

FY26 ₹319M

Net income

FY22 −₹39.6M

FY23 ₹10.1M

FY24 ₹76.3M

FY25 ₹10.1M

FY26 −₹15.9M

Is ALFATRAN fairly valued? → Check now

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is ALFATRAN (ALFATRAN) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹25.70 versus a price of ₹41.69 — about −38% (overvalued). Model-based estimate, not financial advice.

What is the fair value of ALFATRAN?

Our model-based fair value for ALFATRAN is ₹25.70 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹41.69.

What is the quality score of ALFATRAN?

ALFATRAN has a Quality Score of 38/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of ALFATRAN (ALFATRAN)?

ALFATRAN reported trailing-twelve-month revenue of about ₹319M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of ALFATRAN?

The net profit margin of ALFATRAN is about -5.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.